InvestorsHub Logo
Followers 24
Posts 501
Boards Moderated 1
Alias Born 03/09/2014

Re: None

Monday, 08/24/2020 12:41:48 PM

Monday, August 24, 2020 12:41:48 PM

Post# of 694
BMRN
Wedbush analyst Liana Moussatos reiterated a Buy rating on BioMarin Pharmaceuticals-
– Research Report) today and set a price target of $136.00. The company’s shares closed last Wednesday at $75.04.

According to tipranks.com, Moussatos is a 5-star analyst with an average return of 12.2% and a 53.4% success rate.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMRN News